FV
Alloksys Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RESCAP® | Prevention of complications (e.g., Acute Kidney Injury) in patients undergoing cardiothoracic surgery | Phase IIb / III |
Leadership Team at Alloksys Life Sciences
HF
Herman Feil, PhD
CEO
RB
Ruud Brands, PhD
President
WS
Willem Seinen, Prof., PhD
CSO
MV
Marleen Vaes
Medical Director
HK
Hiskias Keizer, PhD
Senior Scientist
RO
Ronald Oosting, PhD
Senior Scientist
DW
Dr. Wen Liem
QP
IG
Ingmar Garrah
Financial and Business Development
FS
Fuhong SU, PhD
Scientific Advisory Board Member
MC
Manuel Carrondo, Prof.
Scientific Advisory Board Member